King-Devick technologies, inc. offers a broad set of evidence-based tools utilizing integrated technology to accurately and objectively assess eye movement (oculomotor) disorders such as saccadic dysfunction and objective tools to assess balance and contrast sensitivity.
King-Devick products have been scientifically validated in more than 200 recent peer-reviewed articles published in elite medical journals related to concussion management, reading solutions, migraine headaches, Alzheimer’s disease, hypoxia, multiple sclerosis, Parkinson’s disease, extreme sleep deprivation, ALS and age-related macular degeneration (AMD).
King-Devick Test in association
with Mayo Clinic
In an effort to increase concussion screening awareness, in 2015, Mayo Clinic and King-Devick technologies, inc. announced that they had executed a licensing agreement to co-brand the King-Devick sideline test to King-Devick Test in association with Mayo Clinic. Read the complete press release here.